论文部分内容阅读
以免疫组织化学S-AP法,应用CD34单克隆抗体特异性标记乳腺癌组织血管内皮细胞,检测乳腺癌组织内的微血管密度(MVD),研究其与预后的关系。结果:MVD最小值为3,最大值为52,平均15±8.5,除组织学分级与MVD有统计学差异之外,肿瘤大小、绝经状态、淋巴结转移状况等均与MVD无关。分析MVD与预后的关系显示,MVD≥15的患者其术后5年生存率为48.6%,而MVD<15的患者的术后5年生存率为81.0%,两组之间经Logrank检验差异有显著性。提示MVD是乳腺癌的有价值的预后指标,而且可能成为一个较有意义、独立的乳腺癌预后因素
Immunohistochemical S-AP method was used to specifically label breast cancer tissue vascular endothelial cells with CD34 monoclonal antibody. Microvessel density (MVD) in breast cancer tissue was detected and its relationship with prognosis was studied. Results: The minimum value of MVD was 3, the maximum value was 52, and the average was 15±8.5. Except for histological grade and MVD, the tumor size, menopausal status, and lymph node metastasis were not related to MVD. Analysis of the relationship between MVD and prognosis showed that the 5-year survival rate was 48.6% in patients with MVD ≥ 15, while the 5-year survival rate was 81.0% in patients with MVD <15. Logrank test the difference was significant. It is suggested that MVD is a valuable prognostic indicator of breast cancer and may become a more meaningful and independent prognostic factor for breast cancer.